Table 1.

Patient demographics and baseline characteristics.

Characteristic	Number of patients (%) N = 18
Age
Median (range)	65 (48–76)
Gender
Male	3 (17%)
Female	15 (83%)
Race/ethnicity
Caucasian	14 (78%)
African American	1 (6%)
Asian	1 (6%)
Hispanic	2 (11%)
Tumor type
Ovarian	4 (22%)
Breast (all ER+ HER2−)	5 (28%)
Prostate	2 (11%)
Other (fallopian tube, endometrial, peritoneal, pancreatic, rectal, gastric, gallbladder)	7 (39%) (1 of each tumor type)
Baseline ECOG performance status
0	4 (22%)
1	14 (78%)
Prior lines of therapy for metastatic disease
2	1 (6%)
3	4 (22%)
4	5 (28%)
5 or more	8 (44%)